SECsense Logo

Opus Genetics, Inc. Amended Form 8-K/A Report: Key Financial Updates

$IRD
Form 8-K/A
Filed on: 2025-01-07
Source
Opus Genetics, Inc. Amended Form 8-K/A Report: Key Financial Updates

Based on the provided section of the financial report, here are the key extracted pieces of information:

  1. Filing Type: The document is an amended Form 8-K/A, which is typically used to report significant events that shareholders should know about, in this case, for Opus Genetics, Inc.
  2. Company Information:
  • Name: Opus Genetics, Inc.
  • State of Incorporation: Delaware (DE)
  • CIK (Central Index Key): 0001228627
  • SEC File Number: 001-34079
  • EIN (Employer Identification Number): 11-3516358
  • Address: 8 Davis Drive, Suite 220, Durham, NC 27709
  • Phone Number: 248-957-9024
  1. Stock Information:
  • Type of Stock: Common Stock
  • Par Value: $0.0001 per share
  • Stock Exchange: NASDAQ (Ticker Symbol: IRD)
  1. Report Period:
  • Filing Date: October 22, 2024
  • Report Period: The report covers the single day of October 22, 2024.
  1. XML and XBRL Context: The document is formatted in XBRL (eXtensible Business Reporting Language), which is used for financial reporting and allows for easier data extraction and analysis.

This information highlights the essential details of the filing, including the company's identity, the nature of the report, and pertinent financial data that may be of interest to investors and analysts.